Chief Financial Officer Kamlesh Agarwal Just Sold A Bunch Of Shares In Himadri Speciality Chemical Limited (NSE:HSCL)

Investors may wish to note that the Chief Financial Officer of Himadri Speciality Chemical Limited, Kamlesh Agarwal, recently netted ₹2.1m from selling stock, receiving an average price of ₹46.73. That might not be a huge sum but it was 97% of their personal holding, so we find it a little discouraging.

View our latest analysis for Himadri Speciality Chemical

The Last 12 Months Of Insider Transactions At Himadri Speciality Chemical

Notably, that recent sale by Kamlesh Agarwal is the biggest insider sale of Himadri Speciality Chemical shares that we've seen in the last year. So what is clear is that an insider saw fit to sell at around the current price of ₹43.60. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. Given that the sale took place at around current prices, it makes us a little cautious but is hardly a major concern.

You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.

Does Himadri Speciality Chemical Boast High Insider Ownership?

Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Himadri Speciality Chemical insiders own about ₹910m worth of shares. That equates to 4.9% of the company. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

So What Does This Data Suggest About Himadri Speciality Chemical Insiders?

An insider hasn't bought Himadri Speciality Chemical stock in the last three months, but there was some selling. Looking to the last twelve months, our data doesn't show any insider buying. While insiders do own a lot of shares in the company (which is good), our analysis of their transactions doesn't make us feel confident about the company. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. In terms of investment risks, we've identified 3 warning signs with Himadri Speciality Chemical and understanding them should be part of your investment process.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

If you’re looking to trade Himadri Speciality Chemical, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Their clients from over 200 countries and territories trade stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
^*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.